Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Use of composite outcomes facilitate core outcome set uptake in rheumatoid arthritis trials

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. How do people with rheumatoid arthritis experience participation in a smoking cessation trial: a qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Adherence to Treat-to-Target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
To use prospectively registered data from the Danish nationwide rheumatological database (DANBIO) to describe disease activity, clinical response, treatment duration and predictors of drug survival (ie, number of days individual patients maintained treatment) and clinical response among patients with ankylosing spondylitis (AS) receiving their first treatment series with a tumour necrosis factor α (TNFα) inhibitor.
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume69
Issue number11
Pages (from-to)2002-8
Number of pages7
ISSN0003-4967
DOIs
Publication statusPublished - 1 Nov 2010

ID: 31048809